DYADIC INTERNATIONAL INC Equity Securities, FV-NI, Realized Gain (Loss)
DYADIC INTERNATIONAL INC (DYAI) reported Equity Securities, FV-NI, Realized Gain (Loss) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-29.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiRealizedGainLoss · last filed 2023-03-29
- DYADIC INTERNATIONAL INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2022-12-31 was $0.00.
- DYADIC INTERNATIONAL INC equity securities, fv-ni, realized gain (loss) for the quarter ending 2021-12-31 was $0.00.
- DYADIC INTERNATIONAL INC equity securities, fv-ni, realized gain (loss) for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- DYADIC INTERNATIONAL INC equity securities, fv-ni, realized gain (loss) for fiscal 2021 was $1.61M.
| Period end | Equity Securities, FV-NI, Realized Gain (Loss) 3 month | Equity Securities, FV-NI, Realized Gain (Loss) 9 month | Equity Securities, FV-NI, Realized Gain (Loss) 12 month |
|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $0.00 10-K · filed 2023-03-29 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $1.61M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $1.61M 10-Q · filed 2022-11-10 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |